DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?
- PMID: 21077744
- DOI: 10.3109/10428194.2010.527410
DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?
Comment on
-
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.Leuk Lymphoma. 2010 Nov;51(11):2126-9. doi: 10.3109/10428194.2010.509893. Epub 2010 Sep 21. Leuk Lymphoma. 2010. PMID: 20858096 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical